Mantle Cell Lymphoma | Topics

Survival Benefit of Autologous HSCT in Mantle Cell Lymphoma Confirmed in Post Hoc Analysis
September 03, 2021

Autologous hematopoietic stem-cell transplantation appears to improved survival compared with interferon alfa maintenance therapy for patients with previously untreated mantle cell lymphoma.

Treatment With Ibrutinib Plus or Minus Rituximab Associated With Significantly Lower Monthly Cost vs Chemoimmunotherapy in R/R MCL
August 11, 2021

Treatment with ibrutinib with or without rituximab was associated with a lower monthly health care cost compared with chemoimmunotherapy in a population of patients with relapsed/refractory mantle cell lymphoma.

Zanubrutinib Appears to Elicit Promising Activity in Relapsed/Refractory MCL
July 22, 2021

Patients with relapsed/refractory mantle cell lymphoma experienced promising response rates after undergoing treatment with zanubrutinib.